SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-17-276135
Filing Date
2017-09-05
Accepted
2017-09-05 08:02:31
Documents
63
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d410307d10k.htm 10-K 588177
2 EX-23.1 d410307dex231.htm EX-23.1 1752
3 EX-31.1 d410307dex311.htm EX-31.1 9498
4 EX-31.2 d410307dex312.htm EX-31.2 9501
5 EX-32.1 d410307dex321.htm EX-32.1 3717
12 GRAPHIC g410307g36f84.jpg GRAPHIC 32900
  Complete submission text file 0001193125-17-276135.txt   3743763

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT meip-20170630.xml EX-101.INS 572223
7 XBRL TAXONOMY EXTENSION SCHEMA meip-20170630.xsd EX-101.SCH 42897
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20170630_cal.xml EX-101.CAL 57711
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20170630_def.xml EX-101.DEF 274338
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20170630_lab.xml EX-101.LAB 383950
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20170630_pre.xml EX-101.PRE 322800
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-50484 | Film No.: 171067432
SIC: 2834 Pharmaceutical Preparations